Gene: CEP76
Official Full Name: centrosomal protein 76provided by HGNC
Gene Summary: This gene encodes a centrosomal protein which regulates centriole amplification by limiting centriole duplication to once per cell cycle. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18816 | CEP76 Knockout cell line (HeLa) | Human | CEP76 | 1:3~1:6 | Negative | Online Inquiry |
KO18817 | CEP76 Knockout cell line (HCT 116) | Human | CEP76 | 1:2~1:4 | Negative | Online Inquiry |
KO18818 | CEP76 Knockout cell line (HEK293) | Human | CEP76 | 1:3~1:6 | Negative | Online Inquiry |
KO18819 | CEP76 Knockout cell line (A549) | Human | CEP76 | 1:3~1:4 | Negative | Online Inquiry |
CEP76 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the functions and mechanisms of the CEP76 gene, implicated in cell cycle regulation and centrosome dynamics. These cell lines are created using advanced CRISPR-Cas9 gene editing technology, which allows for precise disruptions of the CEP76 gene, providing researchers with valuable tools to investigate its role in cellular processes and disease mechanisms.
The key function of these knockout cell lines lies in their ability to elucidate the physiological effects associated with the loss of CEP76 expression. By observing changes in cell morphology, proliferation rates, and centrosome behavior, scientists can gain insights into how CEP76 contributes to critical biological processes such as mitosis, intracellular signaling, and DNA repair. This understanding is particularly essential in cancer research, where dysregulation of cell cycle genes is a hallmark.
In research settings, CEP76 Gene Knockout Cell Lines offer significant advantages over traditional models. They provide a more accurate representation of gene function under conditions that closely mimic human pathophysiology. Moreover, by enabling high-throughput screening of drug candidates and genetic modifiers, these cell lines can accelerate therapeutic discovery in oncology and other fields.
Researchers and clinicians will find immense value in these cell lines for their ability to streamline experimental designs while increasing reproducibility and specificity. The reduction of off-target effects associated with gene editing methods enhances confidence in data, making these cell lines indispensable for advancing scientific knowledge and clinical applications.
Our company is dedicated to delivering high-quality biological products, ensuring that our customers have access to cutting-edge tools like CEP76 Gene Knockout Cell Lines, backed by years of expertise in molecular biology and genetic engineering. With our commitment to excellence, we provide researchers with innovative solutions to drive their investigative endeavors forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.